BIX-01294 sensitizes renal cancer Caki cells to TRAIL-induced apoptosis through downregulation of survivin expression and upregulation of DR5 expression

BIX-01294 (BIX), a G9a histone methyltransferase inhibitor, has been reported for its anti-proliferative and anticancer activities against various cancer cell lines. In this study, we investigated whether BIX could sensitize TRAIL-mediated apoptosis in various cancer cells. Combined treatment with B...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Seon Min, Seo, Seung Un, Min, Kyoung-Jin, Kwon, Taeg Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841352/
https://www.ncbi.nlm.nih.gov/pubmed/29531826
http://dx.doi.org/10.1038/s41420-018-0035-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841352/
https://www.ncbi.nlm.nih.gov/pubmed/29531826
http://dx.doi.org/10.1038/s41420-018-0035-8

Ejemplares similares